Table 5 The Spearman’s correlations between RCe and RCn according to TGe-low group and TGe-high group
|  | Fasting | 2 h postprandial | 4 h postprandial |  | |||||
|---|---|---|---|---|---|---|---|---|---|
Spearman R (P value) | Slope | Intercept | Spearman R (P value) | Slope | Intercept | Spearman R (P value) | Slope | Intercept | |
All subjects (n = 98) | |||||||||
 TGe-low group (<  150 mg/dL) | 0.215 (0.111) | 0.26 ± 0.10 | 12.31 ± 1.84 | 0.119 (0.475) | 0.19 ± 0.17 | 15.47 ± 2.71 | 0.219 (0.181) | 0.25 ± 0.17 | 12.47 ± 3.08 |
 TGe-high group (≥ 150 mg/dL) | 0.475 (0.001*) | 0.43 ± 0.10 | 11.43 ± 3.33 | 0.526(< 0.001*) | 0.49 ± 0.09 | 10.84 ± 2.97 | 0.567 (< 0.001*) | 0.99 ± 0.17 | 0.94 ± 5.78 |
Non-CAD (n = 62) | |||||||||
 TGe-low group (<  150 mg/dL) | 0.250 (0.115) | 0.31 ± 0.12 | 11.10 ± 2.30 | −0.081 (0.714) | −0.14 ± 0.24 | 19.44 ± 3.98 | 0.197 (0.357) | 0.29 ± 0.21 | 10.77 ± 4.08 |
 TGe-high group (≥ 150 mg/dL) | 0.350 (0.210) | 0.52 ± 0.18 | 6.30 ± 5.73 | 0.550(< 0.001*) | 0.40 ± 0.11 | 10.73 ± 3.22 | 0.431 (0.008*) | 0.74 ± 0.26 | 7.46 ± 8.79 |
CAD (n = 36) | |||||||||
 TGe-low group (<  150 mg/dL) | 0.195 (0.487) | 0.09 ± 0.21 | 15.41 ± 3.28 | 0.794(< 0.001*) | 0.63 ± 0.14 | 11.69 ± 2.17 | 0.574 (0.025) | 0.39 ± 0.30 | 11.89 ± 5.02 |
 TGe-high group (≥ 150 mg/dL) | 0.654 (0.001*) | 0.36 ± 0.11 | 16.06 ± 3.78 | 0.673 (0.001*) | 0.50 ± 0.14 | 15.48 ± 4.88 | 0.793(< 0.001*) | 1.16 ± 0.20 | −1.68 ± 7.46 |
All statistics (n = 294) | Spearman R (P value) | Slope | Intercept | ||||||
 TGe-low group (<  150 mg/dL) | 0.147 (0.091) | 0.21 ± 0.08 | 13.75 ± 1.35 | ||||||
 TGe-high group (≥ 150 mg/dL) | 0.526(< 0.001*) | 0.68 ± 0.08 | 6.80 ± 2.67 | ||||||